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In this thesis I explore the stability and the breakdown of stability of biological systems. The
main examples are the blood system and invasion of cancer. However, the models presented in
the thesis apply to several other examples.
Biological systems are characterised by both competition and cooperation. Cooperation is
based on an unsolvable dilemma: Even though mutual cooperation leads to higher payo↵ than
mutual defection, a defector has higher payo↵ than a co-operator when they meet. It is not
possible to represent this dilemma with a linear and deterministic model. Hence, the dilemma
of cooperation must have a nonlinear and/or stochastic representation.
More general, by using a linearised model to describe a biological system, one might lose
dimensions inherent in the complexity of the system. In this thesis I illustrate that a nonlinear
description of a biological system is potentially more accurate and might provide new information.
The thesis is made up of three papers. Paper 3 presents the most general model which consid-
ers a relative stable population that is invaded by an alternative strategy. That is, a new type of
individual is in general not advantageous when it appears in stable population. The newcomers
can grow in number due to stochasticity. However, they can only become advantageous if they
manage to change the environment in such a way that they increase their fitness. The model
presented in paper 3 is an extension of the Moran process that captures this dynamics.
Paper 2 proposes a model that links self-organisation with symmetric and asymmetric cell
division. The model assumes that cell divisions are completely random events, and that the
daughter cells resulting from asymmetric and symmetric divisions are, in general equal, and
still, the tissue has the flexibility to self-renew, produce mature cells and regenerate, due to
self-organisation.
Paper 1 presents a model that illustrates that if symmetric stem cell division is regulated by
di↵erentiated cells, then the fitness of the stem cells can be a↵ected by modifying the death rate
of the mature cells. This result is interesting because stem cells are less sensitive than mature
cells to medical therapy, and our results imply that stem cells can be manipulated indirectly by
medical treatments that target the mature cells.
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Paper 2 Marthe Måløy, Frode Måløy, Per Jakobsen and Bjørn Brandsdal. Dynamic self-
organisation of haematopoiesis and (a)symmetric cell division. Journal of Theoretical Bi-
ology 414, 147–164 (2017).
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The fundamental and defining principles of evolutionary theory are replication, selection and
mutation [1]. Based on these three principles, it is possible to describe a biological system with
mathematical equations. However, since living organisms reproduce, die and change strategy
based on feedback from their environment, it is very hard to derive a mathematical model that
is both general and gives an accurate description of a specific biological system.
An important question, both in this thesis as well as in mathematical modelling in general,
is what level of complexity should be included in a model. For instance, flipping a coin could be
represented by an extremely complex model that includes Newton’s laws, the laws of thermody-
namics and so on. However, a simple stochastic model, with equal probability of head and tail,
is in general better.
For similar reasons, a very simplistic and stochastic model might be the best representation of
blood formation, in general. That is, haematopoiesis is the generation of blood, and at the root of
this process is a small group of slowly replicating cells, called the haematopoietic stem cells [2], [3],
which have the capability to maintain themselves through self-renewal and produce mature
blood cells through di↵erentiation. Under normal conditions, the number of haematopoietic
stem cells is approximately constant, and Lenaerts et al. [4] show that the haematopoietic stem
cells dynamics can be described by the Moran process, which represents the simplest possible
model of stochastic evolutionary dynamics in a finite population. However, the production of
mature blood cells increases after blood loss, and research results by Goko↵ski et al. [5] indicate
that the number of haematopoietic stem cells increases when the number of mature blood cells
decreases. A deterministic model of haematopoietic stem cell dynamics with only one regulation
mechanisme, such as the model presented in paper 1, can give a better description of these
specific data than the Moran process. Nevertheless, as I make a case for in Section 2, because
the regulation of haematopoiesis is an extremely complex process, a model that treats stem cell
behaviour as purely random events fits general data better than a deterministic model with a
single regulation mechanism.
In a nutshell, if a process is “very complex”, it is in general better to use a simple stochastic
model, than a complex deterministic model. However, as discussed more thoroughly in Section 6,
machine learning and neural networks challenge the concept of “very complex”. That is, neural
networks will almost certainly have a transformative impact on modelling high-dimensional com-
plex systems in the years to come. Neural networks have challenged traditional mathematical
models and outperformed competing methods without providing clear evidence why they are
doing so [6].
1 Nonlinearity can generate stochasticity
A human child has 23 chromosomes from each parent and these chromosomes contain basic
genetic rules. However, a child is more than half of each parent, and this illustrates why linear
representation of genetic information is problematic because linear equations cannot produce
something new. On the contrary, nonlinear rules can actually produce something new and
unexpected. That is, even a very simple nonlinear relation can generate complex patterns that
no mathematical tools can penetrate. A good example is the logistic map
Y
T+1 = 4YT (1  YT ), (1)
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which is described in more details below.
In a nutshell, a linear mathematical equation is easy to understand and simple to solve,
whereas a nonlinear mathematical equation might be hard or even impossible to understand and
solve, and it can generate new knowledge. Since living organisms reproduce, die, and change
strategy based on feedback from their environment, their behaviour is seldom captured by lin-
ear equations. Even some of the simplest biological systems require nonlinear representations.
This is illustrated below, where it is shown how the behaviour of a system of replicating indi-
viduals changes dramatically when the description changes from linear to nonlinear, when time
is represented by time steps instead of a continuous variable, and when the feedback from the
environment is delated.
1.1 Population growth
When a population is in an isolated environment, only replication can change the population
size. Suppose that the function x(t) describes the size of an isolated population at time t, and
that the derivative of x(t) with respect to t,
dx
dt , exists. Let b and d denote the birth rate and
the death rate, respectively. Since all changes in x(t) are caused by birth or death, we have that
dx
dt
= bx(t)  dx(t) = rx(t), (2)
where r = b  d. If r is a constant, then the di↵erential equation given above is linear and have
solutions on the form
x(t) = x(0) exp(rt), (3)
where x(0) is the population size at time t = 0. Moreover, if r is positive, then x(t) describes
a growing population in an isolated environment where there is no competition for resources.
Nevertheless, a population cannot expand infinitely. Eventually, resources become limited, and
then competition occurs. Ecologists have introduced a variety of modifications to the linear
di↵erential equation given in (2) to take account of saturation e↵ects. The main idea in all of









where the constant C is the carrying capacity of the population. As discussed in the beginning
of the introduction, most nonlinear problems are very hard, and sometimes even impossible, to
solve. However, the di↵erential equation in (4) is one of relatively few nonlinear problems that
have neat solutions, namely
x(t) =
Cx(0) exp(rt)
C + x(0)(exp(rt)  1) , (5)
where x(0) is the population size at time t = 0.
Some populations nurture their o↵spring before these reach reproductive age, and in this case
it might be better to include di↵erent generations. The following nonlinear recurrence relation









where T is a non-negative integer denoting time steps, X
T
is the population size at time step T ,
and R is a positive constant less than or equal to 4. Like for the continuous di↵erential equation
given in (4), C is the carrying capacity. But in contrast to the continuous case, if the population
described by the discrete representation reaches the the carrying capacity, the population will
get extinct the next time step. The reason why the behaviour of the discrete description of
the population is very di↵erent from the continuous description, is that the feedback from the
environment is implemented di↵erently in the two cases.













The logistic map does not have any neat formula for the solution in terms of T . However, for
R < 4 it is possible to predict the outcome of the logistic map by using advanced mathematical
analysis [7]. On the contrary, for R = 4 we obtain the logistic map given in Equation (1). It
has been proved that the statistical mechanics of this system has exactly the same statistical
properties as a random system. Actually, according to Ian Stewart [7]: “Random means that no
obvious structure exists, but that on average we can say various things, such as how often the
values occur in a given range. Random has carried the connotation of indeterministic, that is, a
system is deterministic if it follows exactly some regular law, random if not”. Nevertheless, the
logistic map given in (1) shows there is no clear distinction between deterministic and random
behaviour, because this map is a deterministic system which behaves randomly.
2 Randomness and self-organisation
The logistic map given in Equation (1) is an example of a deterministic equation which behaves
randomly. And in point of fact, for deterministic, nonlinear, dynamical systems, strange attrac-
tors, chaos and random behaviour are the rule rather than the exception, and as the number of
variables increase, the phenomena become more peculiar [8].
The DNA of cells in a multicellular organism contains deterministic rules. However, complex
and nonlinear interactions between cells can create patterns that not only seem totally random,
but that actually are random. Furthermore, it is possible that the organisms make use of the
randomness, because randomly organised systems can exhibit self-organisation which is a spon-
taneous order that arises from local interactions between parts of an initially disordered system.
This possibility is explored in the next subsection.
2.1 Haematopoiesis and self-organisation
Even though the haematopoietic system in a healthy adult is stable and robust, the behaviour of
each blood cell seems chaotic and random. This indicates that haematopoiesis is a self-organised
process.
A healthy adult contains about five litres blood, which corresponds to about 37⇥ 1015 blood
cells. Each day, the body produces around 10
15
blood cells. Thus, most of the cells in the
haematopoietic system is replaced each month [9].
At the root of the blood forming process are the haematopoietic stem cells, which are lo-
cated within the bone marrow and segregated among di↵erent bones throughout the body.
The haematopoietic stem cells di↵erentiate into progenitor cells, which di↵erentiate into red
blood cells, white blood cells or platelets, through sequential division. Since the number of
haematopoietic stem cells is much smaller than the number of more di↵erentiated blood cells,
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the haematopoietic stem cells must be tightly regulated and protected. The haematopoietic bone
marrow niches may be crucial in both aspects [10], [11]. Since a niche cannot be reconstructed
experimentally, it is di cult to study haematopoietic stem cells in vitro, because stem cell sur-
vival, self-renewal and di↵erentiation are regulated by signals from the niche. Hence, relatively
little is known about the exact behaviour of haematopoietic stem cells. For example, when a
haematopoietic stem cell divides, exactly what determines whether a daughter cell becomes a
stem cell or starts to di↵erentiate, is still unclear. This is related to the symmetry of the stem
cell division, which is discussed in the next subsection.
2.2 Symmetric and asymmetric stem cell division
An important concept related to stem cell self-renewal and di↵erentiation, is the symmetry of
the stem cell division. That is, an asymmetric stem cell division results in one daughter cell that
has stem cell identity, and another daughter cell that starts to di↵erentiate, whereas a symmetric
stem cell division generates two daughter cells that are destined to the same fate [12], [13]. There
are two types of symmetric stem cell division, namely symmetric self-renewal, which results in
two stem cells, and symmetric di↵erentiation, where both daughter cells start to di↵erentiate.
Under normal conditions, the number of cells in a given tissue is approximately constant, and
the stem cells di↵erentiate and self-renew at relatively constant rates to replace mature cells and
to keep the stem cell number at a certain normal level [14], [15]. By dividing asymmetrically,
the stem cells manage to both self-renew and produce di↵erentiated cells in a single division.
However, a disadvantage of asymmetric stem cell division is that it leaves stem cells unable
to expand in number. It is, in general, believed that the stem cells can regenerate [12], [13].
For instance, haematopoietic stem cells can expand rapidly in response to injury to the bone
marrow, such as stem cell transplantation [16]. Hence, asymmetric self-renewal cannot be the
complete story, since it leaves stem cells unable to expand in number. The number of stem
cells increases by one after symmetric self-renewal. Since the haematopoietic bone marrow can
regenerate after injury, it is likely that the rate of symmetric self-renewal depends on the number
of haematopoietic stem cells. On the contrary, the number of stem cells decreases by one after
a symmetric commitment. Thus, the two types of symmetric divisions must occur at the same
rate under normal conditions.
As discussed more thoroughly in paper 2, several experiments on Safari cats by Abkowitz et al.
indicate that haematopoietic stem cells divide mostly asymmetrically under normal conditions,
whereas when the haematopoietic bone marrow niche regenerates after injury, the haematopoietic
stem cells start to divide symmetrically [16], [17], [18]. But does this mean that a stem cell
somehow ”knows” that it must divide asymmetrically under normal conditions and self-renew
symmetrically when stem cells need to be replaced? This would also mean that the daughter
cells inherit this ”knowledge”. However, as discussed in paper 2, the assumption that each cell
”knows” how to behave in di↵erent situations is too rigorous and potentially misleading. Thus,
it is more likely that each stem cell behaves completely random. Nevertheless, the stem cells
divide mostly asymmetrically under normal conditions and symmetrically under regeneration,
due to dynamic regulation and self-organisation in the haematopoietic bone marrow niche.
As discussed more thoroughly in paper 2, several experiments on Drosophila germline stem
cells indicate that the stem cell niche can contain up to a certain number of cells, and that
the niche is approximately full under normal conditions. When a stem cell divides, one of the
daughters inherits the mother’s place in the niche and retains stem cell identity. The fate of the
second daughter depends on whether there is a vacant place in the niche or not. In the first case,
the second daughter daughter remains in the niche and retains stem cell identity. If the niche
is full, the second daughter is placed outside the niche, and loses its stem cell identity. Thus,
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research on Drosophila germline stem cells indicates that the stem cells do not ”know” whether
they must divide asymmetrically or symmetrically. That is, the stem cells divide randomly, and
the availability of the niche, and perhaps some other factors, determines whether the division
is asymmetric or symmetric. This implies that an undi↵erentiated cell must be in the niche to
function as a stem cell: Once a cell is placed outside the niche, it is no longer a stem cell.
3 Moran process and the invasion of mutants
As discussed in the previous subsection, under normal conditions, the rate of symmetric self-
renewal must equal the rate at which the stem cells leave the niche, and in this case, the
haematopoietic stem cell dynamics can be described by the Moran process, which assumes that
the population size is constant and that at each time step, a random cell is selected to self-
renew symmetrically and a random cell is selected to leave the growth environment. Dingli et
al. present a version of the Moran process which includes all types of stem cell division [19].
However, for simplicity, we only consider symmetric stem cell division here.
Genetic changes called mutations can occur in any cell that divides [20]. Even though most
mutations are harmless to the body, progressive accumulation of mutations can lead to cancer
[21].
Results from theoretical work indicate that the tissue architecture of the haematopoietic
system, where only a small number of stem cells have the ability to self-renew, has evolved
to minimise the risk of malignant transformations [19]– [22]. That is, if a mutation occurs in a
mature blood cell, it is likely to be washed out of the system before it becomes a cancer phenotype,
because these cells do not self-renew. On the other hand, a mutation in a haematopoietic stem cell
can generate a di↵erent type of stem cell, denoted mutant stem cell. This leads to an evolutionary
process with competition between the mutant stem cells and the normal stem cells [1]. Lenaerts
et al. [4] show that this competition dynamics might be captured by the Moran process. That is,
the Moran process assumes that initially, all the stem cells are normal. When a normal stem cell
self-renews, a mutation that creates a mutant stem cell occurs with probability u. The normal
stem cell self-renews at rate 1 whereas the mutant stem cells self-renew at rate r. All stem cells
are selected to leave the niche at the same rate. Hence, the mutant type is advantageous if r > 1,
neutral if r = 1 and disadvantageous if r < 1. At each time step, the number of mutant stem
cells can either increase by one, remain constant or decrease by one. The probability for these
three events are
P (i+ 1|i) = u(N   i) + ri




P (i  1|i) = (1  u)(N   i)




P (i|i) = 1  P (i+ 1|i)  P (i  1|i), (9)
respectively, where N is the number of stem cells in the niche and i is the number of mutants.
If u is su ciently small, the mutant type typically has time to take over the whole niche or get
extinct before another mutant is created from the normal type. By using the approximation
u ⇡ 0, Wodarz and Komarova [23] show that the probability that i mutant stem cells eventually

















if it is a neutral Moran process, i.e. r = 1.
The reason why the mutant type can invade the whole niche, starting from a single mutant
stem cell, is that the stem cells self-renew symmetrically. Note that if the stem cells only divided
asymmetrically and no new mutation in a normal stem cell occurred, the number of mutants
would remain constant. However, most type of cancers require more than one mutation, and it
is illustrated in the paper by Shahriyari and Komarova [24] that symmetrically dividing cells can
delay a second mutant production compared to an equivalent system with only asymmetrically
dividing stem cells. More precisely, if stem cells only divide asymmetrically, then a mutation
acquired in a stem cell will remain in the system indefinitely, and it is only a matter of time
before the second mutation occurs. On the contrary, a mutant stem cell generated in a symmetric
division has a less certain fate – half of the lineages will di↵erentiate out after the very first
division and only 1/K of all lineages will expand to size K. Thus, that the uncertainty of the
fate of single mutant stem cells can be the reason for the statistically longer time it takes for the
symmetrically dividing stem cell model to produce a double-hit mutant.
Unlike most types of cancers, the first phase of chronic myeloid leukaemia is caused by a single
mutation in a haematopoietic stem cell that creates a leukemic stem cell. Since the mutation
rate from normal cells to leukemic cells is nonzero, it follows from the Moran process that any
person will eventually develop chronic myeloid leukaemia, given that he or she has a su ciently
long life. This might seem to contradict the phrase the survival of the fittest, that originated
from Darwinian evolutionary theory as a way of describing the mechanism of natural selection.
However, as discussed more thoroughly in the next sections, the cooperation among cells in a
multicellular organism is based on an unsolvable dilemma, and, hence, it will sooner or later
dissolve. So maybe we should rather say: the survival of the one that keeps it together until after
successful reproduction. That is, the one thing that protects us from most types of cancer, is
death.
4 The rise and fall of unconditional co-operators: the prisoner’s dilemma
and evolutionary stable games
There are approximately 5⇥ 1030 bacteria on Earth, and their biomass exceeds that of all plants
and animals. Bacteria are present in most habitats: soil, water, radioactive waste, acidic hot
springs, the deep portions of Earth’s crust as well as in symbiotic and parasitic relationships
with plants and animals. Furthermore, bacteria were among the first life forms and will most
likely exist longer than multicellular organisms. It might seem like a mystery that multicellular
organisms evolved from bacteria about 1.5 billion years ago, given that bacteria in so many ways
are fitter than multicellular organisms.
The first life forms adopted the most basic strategy, which is to outcompete other individuals
by dividing as fast as possible, when life started to evolve about four billion years ago [1].
Nevertheless, proliferation requires resources such as nutrient molecules and space, and di↵erent
individuals can have access to di↵erent resources. Thus, cooperation can be beneficial in these
situations [25], [26]. A simplified example of cooperation among single-celled organisms is that
one cell has access to enough nutrient molecules for two cell divisions but no space, whereas
another cell has access to enough space for two cell divisions but no nutrient molecules. Hence,
if both cells share their resources, i.e. mutual cooperation, they will both reproduce. On the
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contrary, if both cells do not share their resources, i.e. mutual defection, none of the cells
reproduce. However, if only one cell shares its resources and the other does not share, then the
co-operator does not reproduce and loses its resources whereas the defector reproduces twice.
This simple example illuminates the dilemma of cooperation: even though mutual cooperation
leads to higher payo↵ than mutual defection, a defector has higher payo↵ than a co-operator
when they meet. Indeed, this example is a version of the well-known game called the prisoner’s
dilemma [1]. Moreover, it illustrates why unconditional cooperation is an unstable strategy:
Consider a group of co-operators. If a mutation causes a cell to change strategy to defection, this
cell increases its payo↵. On the contrary, a strategy is a Nash equilibrium if no player, which in
our example are cells, can deviate from this strategy and increase its payo↵ [27]. Defection is a
Nash equilibrium both in our example with cells and in prisoner’s dilemma in general, because
if a defector mutates into a co-operator, it increases its payo↵.
A Nash equilibrium is also an evolutionarily stable strategy if selection opposes the invasion
of an alternative strategy [25]. That is, if a su ciently large population adopts an evolutionarily
stable strategy, it cannot be invaded by a alternative strategy that is initially rare. For prisoner’s
dilemma, defection is an evolutionarily stable strategy. Hence, co-operators cannot invade a large
population of defectors. However, as illustrated by the Moran process, a relatively small group
of defectors can be invaded by co-operators. Moreover, if the co-operators develop regulation
mechanisms that control the cooperation, for instance by modifying the microenvironment such
that the defectors lose their advantages, then the group can survive in the long term. Indeed, the
evolution of multicellular organism was driven by increasingly advanced regulation mechanisms
among cooperating cells [1].
5 Evolution of multicellular organisms: From randomness to strict reg-
ulation and back
The healthy life and development of an advanced multicellular organism, for instance a human
being, depend upon the cooperation between millions of cells. Nevertheless, as discussed in
Section 4, unconditional cooperation, such as the cooperation given in the prisoner’s dilemma,
is an unstable strategy. Hence, cooperation among cells in an advanced multicellular organism
must be regulated by by a complex network of cellular checkpoints and signals.
Multicellular organisms consists of more than one cell. Similar to single-celled organisms that
belong to a colony, the cells in a multicellular organism must cooperate. Be that as it may, even
the simplest multicellular organisms have cells that depend on each other to survive, whereas
the single-celled organisms that live in colonies, can survive on their own.
Multicellular organisms evolved from colonies of single-celled organisms. As discussed in the
previous section, cooperating cells are vulnerable to mutants that change strategy to defection
since these cells can invade the colony by exploiting the cooperation.
In paper 3, an extension of the Moran process with non-constant fitness is presented. This
model captures the competition between co-operators and defectors, but also how the co-operators
can change their environment such that the fitness of the defectors is reduced.
Advanced multicellular organisms, such as human beings, are maintained by very complex
regulation networks. And, as illustrated in Section 1, as interactions get more complex and
nonlinear, they can generate chaos and random behaviour. Indeed, as discussed in Section 2, it
is possible that advanced multicellular organisms have evolved to make use of the randomness
that is generated by the complexity of the multiple signals.
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5.1 Multicellularity and cancer
The cooperation among cells in a multi-cellular organism is regulated by advanced control mech-
anisms that promote stability for a relatively long time. Nevertheless, multicellular organisms
and all other forms of cooperation will eventually break down because natural selection favours
defection.
Since children need care of for several years, humans must have a long life to reproduce
successfully. As discussed in Section 3, mutations can occur in any cell that divides [20], and
even though most mutations do not harm the body, progressive accumulation of mutations can
lead to cancer. That is, mutations in the genetic code can make a cell ignore signals from other
cells. For example, a mutant cell can divide when it is not needed and fail to undergo apoptosis.
In general, mutant cells that stop cooperating are attacked by the defence system of the body, for
instance killer T-cells. Thus, as discussed more thoroughly in paper 3, mutant cells are in most
cases disadvantageous when they first appear in the body. However, if the mutant type manages
to change the microenvironment such that at least some variants of the mutant cells become
advantageous, the mutant type is likely to spread and cause cancer, which is the breakdown of
cellular cooperation. That is, cancer is really a calculated risk of multicellularity: Cooperation
is not a stable state, and hence, it will eventually break down. Control mechanisms increase the
probability that the cooperation lasts long enough to lead to successful reproduction. However,
there is no guarantee that mutations create defective cells that escape the control network and
destroy the body.
Some cancer cells are programmed to adopt the strategy of primitive single-celled organisms:
divide as fast as possible and outcompete all other cells. Healthy human cells cannot survive on
their own. On the other hand, cancer cells might behave more like single-celled organisms and
in some cases they can survive on their own. An example is the HeLa cell line, which are the
cancer cells of Henrietta Lacks who died of cervical cancer in 1951. The HeLa cell is still used
for scientific pursuits [28].
As discussed more thoroughly in Section 11, even though treatment for cancer and other
genetic diseases are getting better every year, many types of cancer are so complex that we
might never fully understand them. Nevertheless, machine learning and deep neural networks
challenge the concept of “very complex”, and will almost certainly have a transformative impact
on modelling high-dimensional complex systems, such as cancer, in the years to come.
6 Machine learning
Machine learning enables computer systems to learn through progressively improving perfor-
mance on a specific task. That is, the computer system is not explicitly programmed, but uses
statistical techniques on big data. Deep neural networks are a type of machine learning that is
inspired by biological neural networks. Deep neural networks have become the dominant mining
tool for big data applications in the last decade, and it is expected that this type of machine
learning will make their mark in the general area of high-dimensional, complex dynamical sys-
tems [6].
Neural networks are inspired by the work of Hubel and Wiesel on the primary visual cortex
of cats [29], which they won the Nobel prize for. Their experiments demonstrated that neuronal
networks were organised in hierarchical layers of cells that process visual stimulus. The first
mathematical model of a neural network was presented in 1980 by Fukushima et. al [30], but
up until the last decade, the neural networks have not been widely used. The recent success of
deep neural networks has two major reasons [6], namely:
1. The continued growth of computional power.
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2. Exceptionally large labelled data sets which take advantage of the power of multi-layers
(deep) architecture.
Despite the success of deep neural networks, several basic questions remain wide open, for
instance:
1. How many layers are necessary for a given data set?
2. How many nodes at each layer are needed?
3. How big must my data set be to properly train the network?
4. What guarantees exist that the mathematical architecture can produce a good predictor
of the data?
5. What is the uncertainty and/or statistical confidence in deep neural network output?
6. Can I actually predict data well outside my training data?
7. Can I guarantee that I am not overfitting my data with such a large network.




In this part, the three papers which make up the thesis, are presented and discussed.
Paper 3, which was published in 2018, presents a model that capture the dynamics that occurs
when a relatively stable population is invaded by an alternative strategy. Since this model is
the most general, it is discussed first. Paper 2 was published in 2017 and presents a model of
haematopoiesis that links self-organisation with symmetric and asymmetric cell division. This
model can reproduce several experimental results. In paper 1 from 2015 we use a mathematical
model to show that if symmetric cell division is regulated by di↵erentiated cells, then changes
in the population dynamics of the di↵erentiated cells can lead to changes in the population
dynamics of the stem cells.
7 Paper 3: Extended Moran process that captures the struggle for
fitness
Natural selection can cause evolution if there is enough variation in a population. When a mutant
is generated in a stable population, the ability to create new variants is important for the mutant
type if it is going to have any chance to invade the population. However, as discussed in Section
4, no individual has anything to gain from changing only its strategy in an evolutionary stable
population [27], and this indicates that the mutant type must also change its environment to
become advantageous.
That is, when a mutant is generated in a relatively stable population, it is most likely not
advantageous. However, the number of mutants can grow due to stochasticity, and indeed, the
mutants can invade a relatively small population, as illustrated by the Moran process presented in
Section 3. Nevertheless, the mutants become advantageous only if they change their environment
such that their fitness increases. This dynamics was present in the evolution of cooperation
among bacteria and multicellularity [26], [31], [32], the invasion of cancer [33] and evolution of
ideas that contradict social norms [34], [35]. In paper 3, we propose an extension of the Moran
process with non-constant fitness that captures this dynamics. To be ore specific, individuals
of the population can change the environment in such a way that the fitness landscape of the
population is modified. That is, the model presented in paper 3 captures the struggle for fitness
as well as the competition between di↵erent types of individuals.
Interestingly, the model can capture the invasion of defection as well as invasion of co-
operators. That is, unconditional co-operators are expected to be exploited until they are
extinct if they appear in a large group of defectors. The best possible scenario for this type
of co-operators is that they manage to change their environment such that another type of co-
operators that only cooperate under certain conditions, becomes advantageous. Similarly, when
defectors appear in a regulated cooperation, the first generation of defectors typically dies while
changing the environment such that coming generations become more advantageous.
7.1 Invasion of co-operators
As discussed in Section 4, it might seem like a mystery that multicellular organisms evolved from
bacteria since natural selection favours defection over cooperation. The model presented in paper
3 illustrates that a small group of co-operators can invade a large population of defectors if they
manage to change the environment such that defection becomes a disadvantageous strategy. That
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is, the model presented in paper 3 assumes that initially the population dynamics is captured by
a neutral Moran process, described in Subsection 3, and that all the individuals in the population
are single-celled organisms that defect. A mutation can create a single-celled organism that co-
operate. In this model, cooperation is captured by so-called detain entities that are activated
by the co-operators. If a detain entity and a co-operator located at the same site, then the
co-operator can be selected to die to give room for reproduction. On the other hand, the
defectors ignore the detain entities, but reproduce if there is room for new daughter cells. Thus,
the defectors are initially fitter than the co-operators. However, due to stochasticity, the co-
operators can avoid extinction, and what is more, the model has an additional parameter called
the temperature. In this example, the temperature represents regulation mechanisms. That is,
initially, when there are only defectors in the population, the temperature is zero. However, the
co-operators raise the temperature, and when the temperature reaches a certain limit, ⌥, the
regulation mechanisms start to kill the single-celled organisms that defect, and hence, defection
becomes a disadvantageous strategy in the population.
7.2 Invasion of defectors and the Warburg e↵ect
The model presented in paper 3 can also capture the dynamics of cancer invasion in solid tissues.
As discussed more thoroughly in Subsection 5, mutant cells are in general not advantageous
when they first appear in a human body because these cells are attacked by the defence system
of the body. In this example, the detain entities represent the immune response. However, it is
assumed that the immune cells are activated only if the mutant cells are harming healthy tissue.
Moreover, the body can limit the blood flow to the microenvironment where the mutant cells are
located. Consequently, the mutant cells break down the end product of glycolysis anaerobically,
and this causes an acidic microenvironment. Hence, the temperature represents the acid level in
the model, and it is assumed that the death rate of the healthy cells and the mutant cells that
are not acid-resistant, increase when the acid level reaches the limit ⌥.
To be more concrete, when the first mutant cell is generated, the acid level is zero. The
mutant cells raise the acid level, but as long as the healthy tissue is not harmed, the competition
dynamics between the healthy cells and the mutants cells is captured by the neutral Moran
process. However, when the acid level reaches ⌥, the healthy tissue is damaged, and consequently,
the immune cells are activated. If none of the mutant cells are acid resistant, then the mutant
type becomes disadvantageous, whereas if the mutant cells have generated a type of cells that are
acid-resistant, then these cells are advantageous as long as there are less than N immune cells
in the microenvironment. Hence, there is a race between the resistant mutants and the immune
cells to reach population size N . If the immune cells respond quickly and reach population size
N before the healthy cells in the microenvironment are extinct, the acid-resistant mutants are
neutralised. In this case, the mutant cells are vulnerable to new immune attacks. On the other
hand, the invasion of the resistant mutants represents the onset of a much more aggressive form
of cancer, and in point of fact, in many cases, cancer cells exhibit glucose fermentation even
when there is enough oxygen present. This is called the Warburg e↵ect [33].
7.3 Further work
The model presented in paper 3 could be extended by including the interplay between evolu-
tion and learning, which is an important issue in evolutionary computation [36]. This plays a
significant role in application areas that were used as examples in paper 3, such as biological
modelling, multi-agent systems, economics and politics. All of these studies involve systems of
interacting autonomous individuals in a population, and this raises several questions, like “Is
15
there any equilibrium?” and “How can cooperative behaviours evolve?”. It is possible to apply
methods from machine learning to seek an answer to these questions.
In the version of the prisoner’s dilemma given in Subsection 4, single-celled organisms, that
either cooperate or defect, compete in a finite population. Each cell has a fixed strategy, and after
a normal cell division, both daughter cells inherit the strategy of the mother cell. However, when
a cell divides, a mutation that changes the strategy of the daughter cells, can occur. Thus, if the
population is relatively small, the co-operators can invade the population due to stochasticity.
Nevertheless, if the population is su ciently large, it will, eventually, be dominated by defectors,
since defection is an evolutionarily stable strategy.
In contrast, a mix between cooperation and defection is often observed in several examples
of prisoner’s dilemma, for instance in human society [37]. One explanation is that in human
life, a player often expects to meet the same opponent in the future, and he might remember a
previous defection and take revenge [36]. On the other hand, if all the opponents know that a
player always cooperate, they are likely to exploit him and defect. In a nutshell, the players use
previous knowledge to decide whether to cooperate or defect.
In [36], the authors investigate the challenge of developing intelligent machine learning ap-
plications to address the problems of adaptation that arise in multi-agent systems, like expected
long tem profit optimization. Moreover, the authors propose a learning algorithm for the emphit-
erated prisoner’s dilemma problem and show that it performs strictly better than the tit-for-tat
algorithm and many other adaptive and non-adaptive strategies. It would be interesting to study
how these examples apply to the model presented in paper 3.
8 Paper 2: Dynamic self-organisation of haematopoiesis and (a)symmetric
cell division
As discussed in Section 2, the blood system consists of approximately 37 trillion cells, and most
of the di↵erentiated blood cells are replaced each month. Hence, it is likely that haematopoiesis
is regulated by self-organisation.
The model presented in paper 2 has a flexible and dynamically regulated self-organisation
based on cell–cell and cell–environment interactions and extracellular regulations. What is more,
the model links symmetric and asymmetric cell division with self-organisation, and as far as we
know, our model is the first to make this connection.
The classical definition of a stem cell is an undi↵erentiated cell capable of self-renewal, pro-
duction of a large number of di↵erentiated cells, regenerating tissue after injury and a flexibility
in the use of these options. This definition is fundamentally based on a functional perspective.
As discussed by Loe✏er and Roeder [38], the flexibility criterion attracted little attention when
the definition of stem cells was first introduced. Yet considerable experimental results indicate
that flexibility is a fundamental property of the stem cells [39], [40], [41]. For example, Zhang
et al. [39] managed to bias the degree of lineage commitment by several maneuvers that altered
the growth environment of the haematopoietic system.
Furthermore, many experiments show that haematopoietic stem cells can be manipulated
such that they act as stem cells for another tissue such as neuronal and myogenic [40]. These
experiments indicate that the growth environment is an important factor when tissue specification
of stem cells are redirected.
The bone marrow niche contains both localised signalling cells and an extracellular matrix
that support stem cell behaviour and control the fate of the undi↵erentiated cells [10], [11].
However, since it is not possible to reconstruct a bone marrow niche experimentally, the exact
behaviour of haematopoietic stem cells is unknown. On the other hand, research on Drosophila
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germline stem cells provides a clearcut example of how the niche maintains stem cell behaviour.
That is, experiments on Drosophila germline stem cells support the following conjectures:
1. The stem cell niche promotes stem cell maintenance.
2. The stem cells self-renew at random.
3. When a stem cell self-renews, one of the daughter cells inherits the mother’s place in the
stem cell niche and retains stem cell identity, whereas the fate of the second daughter
depends on the availability of space in the stem cell compartment – it either slips into a
random vacant place in the stem cell compartment and remains a stem cell (symmetric
self-renewal), or the second daughter leaves the stem cell compartment and loses its stem
cell identity (asymmetric self-renewal).
4. Under normal conditions, the stem cell compartment is approximately full, and the stem
cells typically self-renew asymmetrically.
5. When the stem cell compartment is not full, the rate of symmetric self-renewal generally
increases, which leads to an expansion in the number of stem cells. The cells swift back to
asymmetric self-renewal as the stem cell compartment reaches normal conditions.
The model presented in paper 2 assumes that Conjecture 1—6 also hold for the haematopoietic
system. More specifically, the model assumes that all haematopoietic cell divisions occur ran-
domly and that a haematopoietic stem cell is an undi↵erentiated cell located in a niche. That
is, if a stem cell leaves the niche, it loses its stem cell identity. What is more, the daughter
cells resulting from a stem cell division are phenotypically identical regardless of whether the
division was asymmetric or symmetric. Due to self-organisation, the daughter cells remain in the
niche and obtain stem cell identity or are placed outside the niche and commit to di↵erentiation,
depending on the need for self-renewal and di↵erentiation. This is implemented by subdividing
the niche into sites which represent signals and the environment as well as physical space.
8.1 Results from experiments on Safari cats can be explained by a self-organised
model
As discussed above, relatively little is known about the exact behavior of the haematopoietic
stem cells. On the contrary, haematopoietic progenitors have been studied both in vivo and in
vitro. Loosely speaking, progenitors are cells on the first stage of the di↵erentiation process.
Abkowitz et al. designed a set of experiments, using female Safari cats, to predict the contri-
bution of haematopoietic stem cells to progenitor cells [17], [16], [42]. The Safari cat is a hybrid
of the Geo↵roy’s cat (a South American wildcat) and a domestic cat (which is of Eurasian ori-
gin). These two species have evolved independently for twelve million years, and have distinct
phenotypes of the X chromosome-linked enzyme glucose-6-phosphate dehydrogenase (G6PD).
Female Safari cats have some cells that contain Geo↵roy-type G6PD (G G6PD) and other cells
that contain domestic-type G6PD (d G6PD). The G6PD phenotype is retained after replication
and di↵erentiation, and is functionally neutral. Therefore, it provides a binary marker of each
cell and its o↵spring. In particular, this means that a progenitor cell that expresses G G6PD
is the daughter of a stem cell that expresses G G6PD, and likewise, a progenitor cell that is d
G6PD-positive is the daughter of a stem cell that is d G6PD-positive. Abkowitz et al. tracked
the contributions of haematopoietic stem cells to the progenitor cells by observing the G6PD
phenotype of haematopoietic progenitor cells.
Abkowitz et al. found that the percentage of progenitor cells expressing d G6PD remained rel-
atively constant in normal female Safari cats. On the contrary, they observed that the percentage
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of progenitor cells expressing d G6PD variated while the cells in the bone marrow regenerated,
and, what is more, they found that the pattern of clonal contribution to haematopoiesis in each
cat was unique. For instance, some of the cats that both had cells expressing d G6PD and cells
expressing D G6PD when the regeneration started, had only cells expressing either d G6PD or D
G6PD when the production of bone marrow cells stabilised after regeneration. Thus, one of the
phenotypes had got extinct during the regeneration. On the contrary, in other cats, the percent-
age of cells expressing d G6PD and D G6PD remained on average relatively constant. Moreover,
in some cats, significant variation in the percentage extended for years after the number of cells
reached normal population levels, whereas in other cats, the percentage remained approximately
constant.
Since the percentage of cells expressing d G6PD remained relatively constant when normal
female Safari cats were observed, the experiments by Abkowitz et al. indicate that haematopoietic
cells divide asymmetrically under normal conditions, because this type of division cannot change
the number of stem cells expressing d G6PD. On the other hand, the number of stem cells
expressing d GPD can increase or decrease by one after a symmetric stem cell division. Hence,
since wide fluctuations in the percentage of cells expressing d G6PD were observed when the bone
marrow regenerated, the experiments by Abkowitz et al. indicate that the rate of symmetric stem
cell division increases during regeneration of the stem cell niche.
Other mathematical models of the haematopoietic system that include symmetric and asym-
metric stem cell division, have been proposed, and they can reproduce several of the results
obtained by Abkowitz et al. For instance, Wodarz and Komarova [23] propose a model where
the haematopoietic stem cells divide asymmetrically under normal conditions and to symmetric
division during regeneration. On the contrary, in the model presented by Abkowitz et al. [18],
the haematopoietic stem cells only divide symmetrically. That is, under normal conditions, the
haematopoietic stem cells undergo symmetric self-renewal and symmetric commitment at the
same, constant rate, and under regeneration, the rate of the former type of division increases.
Even though these models capture important aspects related to stem cell behaviour, it is a draw-
back that stem cell self-renewal and di↵erentiation do not depend on local growth conditions
because this implies that a stem cell somehow “knows” that it must self-renew symmetrically
when stem cells need to be replaced. However, as discussed in Section 2, this assumption is
potentially misleading and too rigorous. On the contrary, since the model presented in paper 2
links self-organisation with symmetric and asymmetric cell division, the rate of symmetric and
asymmetric stem cell division is regulated by the needs of the haematopoietic system.
8.2 Di↵erentiated cells
The model presented in paper 2 also includes the di↵erentiated cells. It is assumed that these cells
go through N stages of di↵erentiation and that the cells that are at stage i in the di↵erentiation
process, are located in the i-th compartment. These compartments represent the sum of signals
in the environment of the cells and not just physical locations. Moreover, it is assumed that the
commited cells can only di↵erentiate symmetrically. That is, if a cell in the i-th compartment
divide, then both daughter cells migrate to the i+1-th compartment. Under normal conditions,
there are approximately 2
i
M cells in the i-th compartment, where M is the number of cells is
stem cell niche when it is full, and the cells commit symmetrically to di↵erentiation at the same,
constant rate. However, the model assumes that there is a feedback from compartment i to




The model presented in paper 2 is very simple with two parameters only, M and K, which are
the number of sites in the stem cell niche and the number of compartments of di↵erentiated cells,
respectively.
In an extended version of the model, the committed haematopoietic cells should be divided
into the erythroid lineage, the lymphoid lineage and the myeloid lineage. The first lineage is
composed of red blood cells, the second of immune cells and the third includes granulocytes,
megakaryocytes and macrophages [9]
It is still not clear exactly how di↵erentiation of haematopoietic cells is regulated. In 1957,
Waddington presented an epigenetic landscape that describes the di↵erentiation of cells as the
trajectories of balls rolling at random into branching valleys, where each branch represents a
developmental state [43]. Based on Waddington’s model, Furusawa and Kaneko propose a dy-
namical system model of cells with intracellular protein expression dynamics and interactions
with each other [44]. The model predicts that cells with irregular, or chaotic, oscillations in
gene expression dynamics have the potential to di↵erentiate into other cell types. During de-
velopment, such complex oscillations are lost successively, leading to loss of pluripotency. Their
results are consistent with the view that pluripotency is a statistical property defined at the
cellular population level, correlating with intra-sample heterogeneity, and driven by the degree
of signalling promiscuity in cells.
To extend the model to include di↵erent lineages of the committed haematopoietic cells, it
could be an advantage to use methods from big data analysis, such as machine learning, because
these methods o↵er new ways to study the genome, transcriptome, proteome, and epigenome
at the single-cell level. An increasing number of single-cell sequencing data makes it possible
to carry out statistical inferences of pluripotency regulating genetic networks. In the work by
Lin et. al, the authors develop a framework based on machine learning which explicitly account
for the promoter architectures and gene state-switching dynamics. Their framework is useful
for disentangling the various contributions that gene switching, external signaling, and network
topology make to the global heterogeneity and dynamics of transcription factor populations.
Their findings indicate that the pluripotent state of the network might be a steady state which
is robust to global variations of gene-switching rates.
Di↵erentiation modifies molecular properties of stem and progenitor cells, which leads to
changing shape and movement characteristics. Buggenthin et al. present a method based on
machine learning that predicts lineage choice in di↵erentiating haematopoietic progenitors. Their
method can detect lineage choice up to three generations before conventional molecular markers
are observable. Thus, their approach manages to identify cells with di↵erentially expressed
lineage-specifying genes without molecular labelling.
9 Paper 1: Stem cell regulation: Implications when di↵erentiated cells
regulate symmetric stem cell division
Similar to the model discussed in the previous section, the model presented in paper 1 is used to
study how stem cell division is regulated by other cells. However, the main focus of this paper
is that changes in the population dynamics of the di↵erentiated cells can lead to changes in the
population dynamics of the stem cells if symmetric stem cell division is regulated by di↵erentiated
cells, and this means that the relative fitness of the stem cells can be a↵ected by modifying the
death rate of the di↵erentiated cells. This result is interesting because stem cells are in general
less sensitive to medical therapy than di↵erentiated cells, and our result implies that stem cells
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can be manipulated indirectly by medical treatments that target the di↵erentiated cells.
9.1 Symmetric stem cell division and cancer
As discussed more thoroughly in Subsection 2.2 and Section 8, the number of stem cells increases
by one after a symmetric self-renewal, whereas after a symmetric di↵erentiation, the number of
stem cells decreases by one.
It is assumed that under normal condition the number of stem cells is approximately constant,
and that these cells self-renew and di↵erentiate at relatively constant rates to keep the number
of stem cells at normal level and replace mature cells [45] Moreover, it has been shown that the
haematopoietic stem cells can expand rapidly in response to stem cell transplantation and other
injuries to the bone marrow. This indicates that the rate of symmetric self-renewal depends on
the number of stem cells in the niche, since this is the only type of division that increases the
number of stem cells.
As discussed more thoroughly in Section 2, the production of mature blood cells increases
after blood loss. A symmetric di↵erentiation produces two daughter cells that commit to di↵eren-
tiations, whereas an asymmetric stem cell division produces only one. However, since asymmetric
stem cell division leaves the stem cell number unchanged, the stem cell niche is protected against
fluctuations if only the di↵erentiated regulate asymmetric stem cell division. Indeed, Wodarz
propose a model where the rate of symmetric self-renewal depends only on the number of stem
cells in the niche, whereas the di↵erentiated cells regulate the rate of asymmetric stem cell di-
vision when there are only healthy cells in the system [46]. This means that the population
dynamics of the stem cell niche is not influenced by the di↵erentiated cells. However, as I make
a case for in Section 8, it is likely that tissues, such as the haematopoietic system, is regulated
by self-organisation and that all three types of stem cell divisions depend on both the number of
stem cells and the number of di↵erentiated cells. In particular, it is also possible that the rate
of symmetric self-renewal increases when the number of di↵erentiated cells is less than under
normal conditions, which means that the number of stem cells increases and that more di↵eren-
tiated cells are produced than under normal conditions. Research by Goko↵ski et al. (2011) on
mice indicates that when there are less di↵erentiated cells than under normal conditions, then
the stem cell populations expand [5]. Indeed, this is the case for the model presented by Lander
et. al [47]. Similarly, the model presented in paper 1 assumes that symmetric self-renewal is
regulated by di↵erentiated cells.
A mutant haematopoietic di↵erentiated cell is likely to be washed out of the system before
it becomes a cancer cell because haematopoietic di↵erentiated cells do not in general self-renew.
On the other hand, if a mutation occur in a haematopoietic stem cell, an evolutionary process
with competition between the normal stem cells and the mutant stem cells might take place [1].
A critical aspect is whether the mutation a↵ects how the mutant stem cells divide. That is,
the population size of the mutants remains constant if they only divide asymmetrically. Since
symmetric di↵erentiation decreases the population size, the mutant stem cells have decreased
fitness if the rate of this type of division increases. And finally, an increased rate of symmetric
self-renewal increases the fitness of the mutant stem cells, because this type of division increases
the population size.
9.2 Treatment of chronic myeloid with the tyrosine kinase inhibitors
Treatment of chronic myeloid with the tyrosine kinase inhibitors such as imatinib, represents a
successful application of molecularly targeted anti-cancer therapy [48] (Druker et al., 1996, 2001;
Kantarjian et al., 2002). These inhibitors reduce the fitness of Philadelphia-positive di↵erentiated
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cells. Nevertheless, the e↵ect on Philadelphia-positive stem cells remain incompletely understood.
For many patients, discontinuation of tyrosine kinase inhibitors results in a relapse of the disease
within a few months [49]. Several explanations have been proposed to explain this phenomenon.
For instance, tyrosine kinase inhibitors might not have any e↵ect on the Philadelphia-positive
stem cells [50], or the Philadelphia-positive stem cells can be susceptible to therapy when they
are in an active state, but they are not be susceptible when they are in quiescent state [51].
Be that as it may, a small study involving 12 patients has shown that in some individuals the
disease has remained undetected for two years after discontinuation of tyrosine kinase inhibitors.
This raises the possibility that tyrosine kinase inhibitors have cured chronic myeloid leukaemia in
these patients [52]. Furthermore, all studies indicate that the e↵ect of tyrosine kinase inhibitors
increases when treatment starts early. The model presented in paper 1 can explain these results:
Tyrosine kinase inhibitors have most likely no direct e↵ect on the Philadelphia-positive stem
cells. Nevertheless, since di↵erentiation regulates the proliferation of the stem cells, the tyrosine
kinase inhibitors can change the population dynamics of the stem cells. More precisely, the
following results observed in studies of chronic myeloid leukaemia patients treated with tyrosine
kinase inhibitors, can be reproduced by the model:
1. The e↵ect of tyrosine kinase inhibitors increases when treatment starts early in disease
progression.
2. In some cases the treatment slows down the disease progression without erasing the Philadelphia-
positive stem cells, which drive the disease.
3. In other cases the treatment reverses the disease progression and seems to erase the
Philadelphia-positive stem cells stem cells.
If a model which assumes that stem cell activity is not regulated by the di↵erentiated cells, is
used, result 1–3 seem contradictory [50]. However, our model implies that these results can be
explained by a negative feedback from the di↵erentiated cells that regulate symmetric stem cell
division [53].
9.3 Further work
The model presented in paper 1 is a simplification of the one presented in paper 2. Hence, the




In 1953, James Watson and Francis Crick discovered that the DNAmolecule exists in the form of a
three-dimensional helix, and this brought new energy to the paradigm of genetic determinism [53],
which claims that any characteristic of a living organism is directly proportional to the genes
expressed in the DNA. This implies that the genetic rules that determine the behaviour of an
organism, can be represented by linear equations, and hence, complex organisms, such as human
beings, should have a much higher number of genes than a less complex organism, such plants.
Another significant milestone in molecular biology was the publication of the complete se-
quence of the human genome in 2003 [54]. The complete human genome is composed of over
three billion bases and contains approximately 20,000 genes that code for proteins. This is much
lower than earlier estimates of 80,000 to 140,000 and astonished the scientific community when
revealed through human genome sequencing. Equally surprising was the finding that genomes
of much simpler organisms contained a higher number of protein-coding genes than humans.
For example, the mustard plant, Arabidopsis thaliana, which used as a model for studying plant
genetics, has a genome size of 125 bases but a higher number of protein-coding genes than hu-
mans [55]. It is now clear that the size of a genome does not correspond with the number of
protein-coding genes, and these do not determine the complexity of an organism.
As I make a case for in Subsection 2, the haematopoietic system is not regulated determin-
istically, but by self-organisation. That is, the body can regenerate blood cells to compensate
for a loss of more than 15 percent of the circulating blood cells, and after a bone marrow trans-
plantation, the haematopoietic stem cells, which are located in the bone marrow, can regenerate.
Moreover, each day the body produces around a billion new blood cells. And since the human
body contains about 37 billion blood cells, this means that most of the circulating blood cells
are replaced each month [9].
Nevertheless, some biological traits are actually determined by a single gene. In contrast to
the haematopoietic system, the fingers only grow out once. The Sonic Hedgehog gene is essential
for normal limb development [56]. When a foetus, lying in the womb, develops fingers, the Sonic
Hedgehog gene sends out a signal to shape the pattern of digits. Normally, five fingers are made.
However, if a mutation occurs in the Sonic Hedgehog gene that turns down the e↵ect of this gene,
then fewer fingers are made, whereas if the mutation increases the e↵ect of the Sonic Hedgehog
gene, then each hand gets an extra finger.
Even though there are some examples where biological traits are determined by a given set of
genes, the publication of the complete sequence of the human genome illuminates that that the
paradigm of genetic determinism does not in general hold true, since complex organisms such as
humans have a lower number of protein-coding genes than much simpler organisms such as the
mustard plant, Arabidopsis thaliana. As illustrated in Subsection 1.1, nonlinear, high-dimensional
and complex interaction between genes and regulation mechanisms can create new phenomena
that cannot be explained by simply analysing the genetic code. Thus, the high complexity of
humans compared to Arabidopsis thaliana might be explained by a higher complexity in the
interaction between genes and regulation mechanisms.
Despite the fact that the paradigm of genetic determinism does not in general hold true, a
new and generally accepted paradigm has not yet been established. There is almost no general
information about nonlinear systems, except that they very often are chaotic and it is quite often
impossible to find an exact solution. Nonlinear systems are often sensitive to starting conditions.
For example, if you were given a list of numbers generated by the logistic map given in Equation
(1) with starting condition Y0 = A, you could not use this list to predict the outcome generated
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by the logistic map with another starting condition, say Y0 = B 6= A. Moreover, nonlinear
systems quite often respond dramatically to changes in the feedback from the environment. For
example, the di↵erential equation in (4) is one of relatively few nonlinear problems that has a
neat solution. Nevertheless, if the feedback from the environment is delayed, then the system
can start to behave chaotically, as described by the logistic map given in (1). This illustrates
that there is no set of mathematical tools that can be used on any nonlinear system. Thus,
each nonlinear system must in general be analysed individually, and this requires more than
basic mathematical knowledge. Moreover, small changes in a nonlinear system can lead to new
behaviour.
10 New methods to analyse complex interactions
Genome editing, such as CRISPR/Cas9, machine learning and big data o↵er new ways to tackle
the problems described above. Machine learning is explored in the previous two parts, whereas
big data and CRISPR/Cas9 are briefly discussed in the following subsections.
10.1 Big data and the impact of the Human Genome Project
“The Human Genome Project led to a paradigm shift in the way science is conducted and
data is shared,” according to researcher in biotechnology, Rehma Chandaria [57]. The Bermuda
Principles are rules for publication of DNA sequence data, and were proposed in 1996 by a group
of international scientists who came together on Bermuda to discuss how sequence data from the
Human Genome Project should be released. Challenging traditional practice in the sciences,
which is to make experimental data available only after publication, the Bermuda Principles
ensures that the data is immediately shared. The original Bermuda Principles were:
1. Automatic release of sequence assemblies larger than 1 kb (preferably within 24 hours).
2. Immediate publication of finished annotated sequences.
3. Aim to make the entire sequence freely available in the public domain for both research
and development in order to maximise benefits to society.
The Bermuda Principles demonstrated how a global community of scientists could collectively
produce and use data far more e ciently than a small group of scientists could.
The price of the Human Genome Project was 3 billion US dollars and it lasted for 13 years [55].
Today it is possible to sequence a human genome within days and it costs less than 1000 dollars.
This big data requires that researchers from di↵erent specialities co-operate to process, analyse,
store and utilise the vast quantities of data.
10.2 CRISPR/Cas9
CRISPR/Cas9 is one of the most e↵ective gene-editing tools the word have seen, and originates
from the immune system of bacteria [58]. With CRISPR/Cas9 the genome can be edited almost
as easily as the text in a book [59]. CRISPR is an abbreviation of Clustered regularly interspaced
short palindromic repeats, and is a family of DNA sequences in archaea and bacteria [60]. The
sequences contain snippets of DNA from viruses that have attacked the prokaryote. Cas9, which is
short for CRISPR-associated protein 9, is an RNA-guided DNA endonuclease enzyme associated
with CRISPR. Cas9 uses the snippets to detect and destroy viruses with similar DNA [61], [62].
A study published on the 2th of August 2017, describe how a group of American and South
Korean scientists for the first time successfully edited genes in human embryos to repair a common
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and serious disease-causing mutation, producing apparently healthy embryos [63]. These results
potentially open the door to preventing 10.000 disorders that are passed down the generations.
However, the main use of CRISPR/Cas9 is less spectacular. CRISPR/Cas9 is mostly used
as a laboratory tool and is for instance used to study the expression of genes. Even though
the complete sequence of the human genome was published 15 years ago, relatively little is
known about how the genes are turned on and o↵ and which traits they influence. Scientists can
gain valuable knowledge by using CRISPR/Cas9 to switch on and o↵ genes in a laboratory, for
example they can study which genes must be turned o↵ in a haematopoietic stem cell for it to
become an immune cell.
Nevertheless, it is not possible to get the complete picture of how genes are regulated inside
the body by just studying cells in a laboratory. For instance, it is still unclear why immune
therapy can cure some cervical cancer patients but has no e↵ect on others. To make hypotheses
about why a medicine does not cure some patients, the researchers can make use of big data sets
from patients by applying methods from machine learning. With solid hypotheses, the use of
CRISPR/Cas9 becomes more e cient.
11 New medicines, new dilemmas
In Norway, lung cancer patients did not get the cost of immune therapy covered by the state until
the end of 2016, whereas in Denmark the same patient group has been o↵ered this treatment at
public hospitals since September 2015 [64]. Similarly, patients with cervical cancer get immune
therapy at public hospitals in Denmark, but not in Norway. In both cases, the state argued that
the prize was too high because immune therapy does not cure all patients.
However, the price of each drug is only high in the beginning. When the e↵ect of the medicine
is more thoroughly documented and more patients can use it, the prize decreases. Large data
sets from patients is of great value for scientific purposes, and there is no obvious reasons why
Norway should contribute less to this research than other countries such as Denmark.
It is not only cancer treatment that creates new dilemmas.
R Spinraza is the first medicine
that has any e↵ect on Spinal Muscular Atrophy (SMA), which is a rare neuromuscular disorder
defined by progressive muscle wasting and loss of motor neurons. Approximately ten children
are born with SMA each year in Norway. About 95 percent of the children with the most severe
form of SMA die before they are two years old, whereas others can have a normal lifespan with
a varying degree of disability. No previous drugs has any proven e↵ect on SMA. Thus, Spinraza
represents a big breakthrough. Moreover, the drug does not only slow down the progression of
the disease – the patients improve motoric function and strengthen the muscles.
In 2017, Biogen, the company that developed Spinraza, let ten Norwegian children with
SMA test the drug for free [65]. One of these children was a 11-month-old baby girl called
Olivia. Olivia has the most severe form of SMA, and after starting the Spinraza treatment,
she manages to sit, eat, hold a toy and turn around. This was impossible for Olivia before the
treatment started. When the free trial ended, the government continued to pay for the Spinraza
treatment for the ten children that had tried the drug for free. However, the government did not
o↵er the remaining 40 children with SMA Spinraza treatment because the prize on the drug was
too high. One of these children is Thea, a two year old girl, and like Olivia, Thea has the most
severe form of SMA. Whereas other toddlers develop control of muscles, which enable walking,
running, jumping and climbing, Thea managed to do less each day. Her parents lived in fear that
she would die while the government negotiated with Biogen, until February 2017, when it was
announced that the government would pay for Spinraza-treatment for all children with SMA.
But the government does not cover this treatment for persons over 18 years of age. The reason
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is that the e↵ect of Spinraza on adults is not documented properly.
However, to evaluate the e↵ect of Spinraza on adults, data from adult patients who actually
use the drug is essential, and it seems reasonable that a rich country such as Norway should be
one of the first to contribute to this research, whereas poorer countries might have no choice but
to wait until the prize decreases and more is known about which patients the drug has any e↵ect
on.
One might argue that Biogen should give a discount on Spinraza-treatment for adult patients
because the company can increase their final reckoning by gaining more information about the
e↵ect of the drug. However, this might increase the prize of the treatment for children.
At the end of the day, Biogen depends on the willingness of the owners to invest in the
company. It is very expensive to develop new medicines. The company Bristol-Myers Squibb,
which developed the immune therapy
R Opdivo, used 40 billion Norwegian Krones on research
and development only in 2014. It is even more risky and potentially costly to try to develop a drug
against disorders which no other drugs has any e↵ect on, which was the case with SMA. Thus,
it is a reasonable assumption that the owners of Biogen were willing to invest in the research
that lead to the development of Spinraza, because there was a big payo↵ if they succeeded. And
indeed, after the launch of Spinraza in 2016, the revenue of Biogen increased by four percent
within a year. In the period from July to September 2017, the income from Spinraza is estimated
to 2.1 billion Norwegian crones. And what is more, the Government Pension Fund of Norway
owns one percentage of the company.
The fact that the Government Pension Fund of Norway is an owner of Biogen, does not mean
that the Norwegian government should accept any price o↵er. However, to me it seems unethical
if Norway waits until the prices drop to buy the drug, and at the same time earn money because
other countries buy the drug when the price is high.
Moreover, the trust in the Norwegian government decreases when Norwegian patients die
while the government is negotiating prices with the drug company, whereas the same patient
group is o↵ered the treatment at public hospitals in other countries.
Maybe the use of new medicines is an investment, both in research and in the welfare state.
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